Hepatitis B patients need antiviral treatment if their condition progresses. Whether hepatitis B requires antiviral treatment depends mainly on the actual condition of the patient, if the patient has an immune tolerance period, that is, in the state of hepatitis B virus carriers, generally do not need to carry out antiviral treatment, once the hepatitis flare-ups, need to consider antiviral treatment in a timely manner. Hepatitis B is a disease caused by the infection of the body with hepatitis B virus, which can be categorized into hepatitis B virus carriers, chronic hepatitis B, hepatitis B cirrhosis and other different types. Although antiviral treatment is the main treatment to deal with hepatitis B at present, not every patient with hepatitis B needs antiviral treatment. According to the Chinese Guidelines for the Prevention and Control of Chronic Hepatitis B, patients with hepatitis B who are in the immune-tolerant stage, i.e., hepatitis B virus carriers, only need regular follow-up and do not need antiviral treatment. For other types of hepatitis B patients, as long as there are indications and conditions permit, antiviral treatment should be standardized. For example, for patients with minor triple positive, antiviral treatment is needed when hepatitis B DNA is persistently positive, while hepatitis B DNA is higher than 20,000 international units per milliliter and alanine aminotransferase is greater than or equal to two times the upper limit of the normal value. In conclusion, it is not possible to generalize whether hepatitis B patients need antiviral treatment or not, it is necessary to judge according to the viral index, liver function, liver puncture biopsy and other tests, and individuals need to actively cooperate with the doctor to carry out diagnosis and treatment.